SHANDONG LUKANG PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.76 CNY | -3.01% |
|
-5.45% | -5.32% |
| May. 29 | China Approves Lukang Pharma's Anti-Asthma Injection | MT |
| Apr. 23 | Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 834M | - | - | - | - | - | |
| 827B | ||||||
| 350B | - | - | - | - | ||
| 319B | ||||||
| 294B | ||||||
| 240B |
